NCT01199744View on ClinicalTrials.gov

Relenza® Sentinel Site Monitoring Program in Japan

CompletedOBSERVATIONAL

Enrollment

1,575

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

April 30, 2010

Conditions

Influenza, Human

Interventions

DRUG

zanamivir

zanamivir

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY